Thyroid function and plasma homocysteine level in vascular dementia patients
Bin Zhao,Jun-jian Zhang,Shi-feng Wang,Guang-hui Chen,Fa-yun Hu
DOI: https://doi.org/10.3321/j.issn:1673-8225.2006.38.025
2006-01-01
Abstract:Aim: To study the relationship between thyroid function and plasma homocysteine (Hcy) levels in patients with vascular dementia (VD). Methods: Totally 38 VD patients and 40 nondemented patients with cerebral infarction detected by CT, who hospitalized in the Department of Neurology, Affiliated Renmin Hospital of Yunyang Medical College between February 2004 and December 2005, were recruited in the study. The VD patients and controls matched each other well in gender and age. And the VD patients were graded with Mini-Mental State Examination (MMSE) scores as illiteracy (≤ 17 points), primary educated (education time ≤ 6 years, ≤ 20 points) and secondary educated or above (education time > 6 years, ≤ 24 points). Their thyroiedine and plasma, Hcy levels were measured by using radioimmunoassay and high-performance liquid chromatography with electrochemical detection, respectively. All the VD patients were tested by the professional researchers with MMSE, Hanchinski Ischemic Score (HIS) and Geriatric Depression Scale (GDS) within 24 hours after hospitalization. The severity of cognition impairment in VD patients was classified by MMSE's scores: mild (20-24 points), moderate (10-19 points) and severe (< 10 points). Results: All the 38 VD patients and 40 controls completed the detections and entered the result analysis.(1)The levels of triiodothyronine (T3), thyroxine (T4) and free T3 (FT3) were all obviously lower in VD patients than in controls [T3: (0.9±0.4), (1.3±0.3) μg/L t=5.012 9, P=0.000 0]; [T4: (92.9±26.4), (110.2±28.7) μg/L, t=2.766 6, P=0.007 1]; [FT3: (3.9±1.8), (7.2±2.1) pmol/L, t=7.433 6, P=0.000 0]. However, total plasma Hcy levels were higher in VD patients, compared with the patients with nondemented cerebral infarction [(29.57±7.12), (24.53±4.98) μmol/L, t=3.637 7, P =0.000 5]. There was no significant difference in the levels of free thyroxin (FT4) and thyroid-stimulating hormone (TSH) between the two groups (P > 0.05).(2) Plasma Hcy, FT3 and T3 concentrations were different significantly in VD patients with different severities of cognition impairment [FT3: (4.7±0.4), (3.5±0.5), (3.1±0.3) pmol/L, t=32.4, P=0.000 0]; [T3: (1.02+0.2), (0.9±0.1), (0.8±0.1) μg/L, t=5.91, P=0.006 1]; [Hcy: (26.52±4.84), (29.59±5.56), (32.71±6.17) μmol/L, F=3.59, P=0.038 0). While the levels of T4 FT4, and TSH were similar in the two groups (P > 0.05). Conclusion: The reduction of thyroiodine and increased levels of Hcy occur in VD patients, and they may be indicative factors for VD's severity.